UNSPSC 51282116: Pivampicillin

This classification denotes a penicillin antibiotic with the molecular formula C22H29N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0HLM346LL7, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (2s-(2alpha,5alpha,6beta(s*)))- but generally known as pivampicillin, which bears US NIH Compound Identifier 33478.

UNSPSC 51282116 Pivampicillin is a Commodity code that in recent state and local procurement activity captures pharmaceutical and medical supply procurements far broader than the code's nominal scope. State and local governments are soliciting naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and exploring direct-to-manufacturer prescription programs. The issuing bodies include county health departments (Seminole County, Florida), city fire departments and purchasing offices (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local members across multiple jurisdictions including Oregon). The mix reflects both direct government procurement and state-coordinated cooperative vehicles that aggregate demand across member entities.

Geographic activity centers on Florida (Seminole County naloxone and drug deactivation systems procurement via IFB, due July 26, 2026; Tampa Fire Department medical and first aid supplies via ITB 26P00145, due March 13, 2026, with an estimated contract value of $700,000.00), Texas (HHS Commission RFI on direct-to-manufacturer prescriptions posted April 3, 2026), and the Upper Midwest through the Minnesota multistate cooperative (RFP S1070000015802 for generic pharmaceuticals and OTC products, due March 26, 2026, serving Minnesota, Oregon, and other participating members). The Tampa procurement carries a 5 percent bid discount for certified Small Local Business Enterprises, not to exceed $10,000, and requires Letters of Intent from listed SLBEs within ten workdays of notice of intent to award. The Minnesota cooperative procurement specifies AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC as authorized wholesalers, with contract effectiveness July 1, 2026 pending product availability by May 15, 2026, and evaluates vendors on price competitiveness (75 percent), fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent).